🔎 Trials Near Me

Home › Chronic Kidney Disease › Maryland

Chronic Kidney Disease clinical trials in Maryland

9 studies for Chronic Kidney Disease are looking for participants at sites in Maryland.

Cities in Maryland

Immune System Related Kidney Disease

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 10 to 99 · All sexes · Updated Nov 12, 2026 · NCT00001979

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #32, Catonsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07268638

A Natural History Study of Metabolic Sizing in Health and Disease

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 99 · All sexes · Updated Oct 27, 2026 · NCT05398783

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

  • John Hopkins Hospital, Baltimore
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT05106387

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Beltsville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993

Kidney Precision Medicine Project

  • Johns Hopkins University, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT04334707

Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Recruiting
Ages 55 and older · All sexes · Updated Apr 7, 2026 · NCT06607913

Transforming Hemodialysis-Related Vascular Access Education

  • Johns Hopkins University, Baltimore
Recruiting
Ages 18 and older · All sexes · Updated Mar 25, 2026 · NCT05997875

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.